Diplomat’s Gary Rice to Co-Present Webinar on Health Plan Strategies for Oral Oncology Therapies
FLINT, Mich. – November 24, 2015 – The nation’s largest independent specialty pharmacy announces an upcoming webinar co-presented by Gary Rice on the pipeline of oncology drugs.
Diplomat Pharmacy, Inc. (NYSE: DPLO) announced today that Gary Rice, Senior Vice President of Clinical Services, Education and Human Resources will be presenting in the upcoming Atlantic Information Services (AIS) online webinar, “Oral Oncology Drugs: Health Plan Strategies for a Dynamic Market” on Dec. 1, 2015. Rice will be co-presenting with Beckie Fenrick, a consultant with the Cambridge Advisory Group, where she leads their pharmacy practice.
The webinar will discuss the rapid growth of oral oncolytics, the impacts they are having on the cost and efficacy of the delivery of health care, and strategies that innovative health plans are developing to manage these therapies.
The 60-minute webinar will take place on Tuesday, Dec. 1, 2015 from 1 p.m. to 2:30 p.m. EST and will be followed by a 30-minute question-and-answer session.
Rice and Fenrick will offer valuable perspectives on the following:
- What are the challenges of oral oncology?
- What is the basis for transitioning to oral cancer care?
- What are the latest data available for oral oncology agents with a focus on outpatient and specialty practice?
- What strategies are top health care plans employing to control the cost of oral oncolytics without compromising patient outcomes?
- What are supportive care requirements that help achieve a positive patient outcome?
For more details and registration information, visit https://aishealth.com/marketplace/c5p27_120115.
To learn more about Diplomat, visit www.diplomat.is.
Diplomat (NYSE: DPLO) serves patients and physicians in all 50 states. Headquartered in Flint, Michigan, the company focuses on medication management programs for people with complex chronic diseases, including oncology, immunology, hepatitis, multiple sclerosis, HIV, specialized infusion therapy and many other serious or long-term conditions. Diplomat opened its doors in 1975 as a neighborhood pharmacy with one essential tenet: “Take good care of patients, and the rest falls into place.” Today, that tradition continues—always focused on improving patient care and clinical adherence. For more information visit www.diplomat.is. Follow us on Twitter and LinkedIn and like us on Facebook.
Kali Lucas, Public Relations Coordinator
810.768.9580 | firstname.lastname@example.org
@PharmacDailyRT @PharmacDaily: @DiplomatRx to distribute Puma Biotechnology’s new cancer drug $DPLO https://t.co/gl0v6WURVV5 days ago
@DiplomatRxNerlynx (neratinib) tablets for HER2+ Breast Cancer in the Extended Adjuvant Setting https://t.co/vi3ACWhbfe5 days ago
@AJPB_JournalRT @AJPB_Journal: Be sure to check out our Insights page featuring videos of Cheryl Allen from @DiplomatRx discussing #RA https://t.co/qxZc…2 weeks ago
@DiplomatRxWe're with @340BCoalition this week in Washington D.C.! Come say hello.3 weeks ago
@SpecialtyPTimesRT @SpecialtyPTimes: Rheumatoid Arthritis Treatment Guidelines https://t.co/sEhe74UozC #rheumatoidarthritis @DiplomatRx3 weeks ago